Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB26FX3UU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,958
Award facts
- Contract value 100% obligated
- $7,957.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,957.68 to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 ml vials. This competitive award, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's DLA Troop Support Medical IDC enables supply of a broad range of pharmaceutical products and medical supplies to support defense healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. This delivery order for IMFINZI, an oncology therapeutic agent, exemplifies the company's role in fulfilling specialized pharmaceutical requirements across the federal health system, with pricing determined through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DB26FX3UU?
SPE2DB26FX3UU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FX3UU worth?
The government has obligated $7,958 on SPE2DB26FX3UU.
Is contract SPE2DB26FX3UU an order under another contract?
Yes. SPE2DB26FX3UU is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3UU competed?
The extent of competition for SPE2DB26FX3UU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award